Patents/Assignees

SANGAMO THERAPEUTICS FRANCE

2 patents in portfolio

US11981739utility2024
Chimeric Antigen Receptor Specific for Interleukin-23 Receptor
0 cites
US11814432utility2023
Anti-hla-a2 Antibodies, Related Chimeric Antigen Receptors, and Uses Thereof
0 cites